[1]Le Bousse-Kerdilès M, Marié-Claire M, Samson M.Cel-lular and molecular mechanisms underlying bone marrow andliver fibrosis:a review[J].Eur cytokine netw, 2008, 19 (2) :69-80.
|
[2] Wynn TA.Cellular and molecular mechanisms of fibrosis[J]. J pathology, 2008, 214 (2) : 199-210.
|
[3] Elsharkawy AM, Oakley F, Mann DA. The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis[J]. Apoptosis, 2005, 10 (5) : 927-939.
|
[4]Li K.Mechanism of curcumine on the suppression of the ex-pression of TGF beta 1 and CTGF signaling pathway on ex-perimental hepatic fibrosis[J].Int J Infect Dis, 2010, 14:39-39.
|
[5] OoYH, Shetty S, Adams DH. The Role of chemokines in the recruitment of lymphocytes to the liver[J]. Dig Dis, 2010, 34 (1) : 45-54.
|
[6]Braz MM, Ramalho FS, Cardoso RL, et al.Slight activationof nuclear factor kappa-B is associated with increased he-patic stellate cell apoptosis in human schistosomal fibrosis[J].Acta Trop, 2010, 113 (1) :66-71.
|
[7]Guicciardi ME, Gores GJ.Apoptosis as a Mechanism for Liv-er Disease Progression[J].Semin Liver Dis, 2010, 30 (4) :402-410.
|
[8]Qin L, Han Y.Epigenetic Repression of Matrix Metalloprotei-nases in Myofibroblastic Hepatic Stellate Cells through His-tone Deacetylases 4 Implication in Tissue Fibrosis[J].Am JPathol, 2010, 177 (4) :1915-1928.
|
[9]Czaja MJ.The future of GI and liver research:editorial per-spectives.Ⅲ.JNK/AP-1 regulation of hepatocyte death[J].Am J Physiol Gastrointest Liver Physiol, 2003, 284 (6) :G875-879.
|
[1] | Ziyi LI, Wanjie ZHANG, Fuchun WANG, Xiaorong MAO, Junfeng LI. Role of T lymphocytes in primary sclerosing cholangitis[J]. Journal of Clinical Hepatology, 2023, 39(12): 2926-2931. doi: 10.3969/j.issn.1001-5256.2023.12.026 |
[2] | Long LIU, Ke SHI, Qun ZHANG, Chongping RAN, Jie HOU, Yi ZHANG, Xianbo WANG. Risk factors for hepatocellular carcinoma in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2021, 37(7): 1589-1593. doi: 10.3969/j.issn.1001-5256.2021.07.022 |
[3] | Yuecheng YU, Chengwei CHEN. Pathogenesis of drug-induced liver injury: Current understanding and future needs[J]. Journal of Clinical Hepatology, 2021, 37(11): 2515-2524. doi: 10.3969/j.issn.1001-5256.2021.11.003 |
[4] | Qu Yao, Zhang Wei. Role of cell apoptosis in the pathogenesis of primary biliary cholangitis[J]. Journal of Clinical Hepatology, 2019, 35(6): 1397-1400. doi: 10.3969/j.issn.1001-5256.2019.06.049 |
[5] | Chang BinXia, Wang Hua, Zou ZhengSheng, Li BaoSen, Gao Bin. Pathogenesis and novel therapeutic targets of alcoholic liver disease[J]. Journal of Clinical Hepatology, 2014, 30(2): 113-117. doi: 10.3969/j.issn.1001-5256.2014.02.004 |
[6] | Liu HongHong, Fu JunLiang, Fu BaoYun, Zhang Zheng, Xu RuoNan, Luo ShengQiang, Shi Ming, Li YongGang, Wang FuSheng. The pathogenesis and risk factors related to prognosis of primary biliary cirrhosis[J]. Journal of Clinical Hepatology, 2012, 28(2): 153-155. |
[7] | Luo FangQiong, Pan Yu, Liu JingJing, Zhang Peng, Niu JunQi, Jiang YanFang. The Impact of Adefovior dipivoxil on Th1/Th2 cytokines in chronic hepatitis B Patients[J]. Journal of Clinical Hepatology, 2010, 26(1): 19-21. |
[8] | Huang ZhongFa, Zhu Qing, Fu QiMei, Bu QuanHui, Shi BinBin. The effect of Interferon treatment on cellular immuneresponses in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2009, 25(5): 326-328. |
[9] | Zhao Shuang, Yan XueBing, Wang JinZhang, Hao JunGui, Wang MingShan, Feng Xia, Wan MeiRong. The study on imblance of cytotoxic T cells subtype (Tc1/Tc2) in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2008, 24(6): 417-419. |
[17] | Yin HongZhu, Liu JinXing, Cao ZhiChen, Li BingShun, Tang HuiHua, Feng ZhongJun. The Study of the role of Soluble Intercellular Adhesion Molecule-1 in Patients with Chronic hepatitis B[J]. Journal of Clinical Hepatology, 2000, 16(4): 230-231. |